| ADT | Androgen deprivation therapy |
| AJCC | American Joint Committee on Cancer |
| AS | Active surveillance |
| CNB | Core needle biopsy |
| CT | Computed tomography |
| DAB | 3,3’-diaminobenzidine |
| DFS | Disease-free survival |
| ESMO | European Society for Medical Oncology |
| GUPS | Genitourinary Pathology Society |
| HE | Hematoxylin and Eosin |
| IDC-P | Intraductal carcinoma of the prostate |
| iPC | Incidental prostate cancer |
| ISUP | International Society of Urological Pathology |
| LVI | Lymphovascular invasion |
| PBCECHT | “Pius Brînzeu” County Emergency Clinical Hospital in Timișoara |
| PC | Prostate cancer |
| PET/CT | Positron Emission Tomography-Computed Tomography |
| PIN | Prostatic intraepithelial neoplasia |
| PNI | Perineural invasion |
| PSA | Prostate-Specific Antigen |
| NCCN | National Comprehensive Cancer Network |
| NE | Neuroendocrine |
| RP | Radical prostatectomy |
| RT | Radiotherapy |
| TNM | Tumor, Node, and Metastasis cancer staging system |
| WHO | World Health Organization |